Pre- and probiotics for allergy prevention: time to revisit recommendations?

Clinical and Experimental Allergy

Volumn 46, Issue 12, 2016, Pages 1506-1521

  Forsberg, A ^a   West, C E ^b,c   Prescott, S L ^b,d   Jenmalm, M C ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b International Inflammation Network (in FLAME) of the World Universities Network   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE; CYTOKINE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ALLERGY; ANTIBODY TITER; ATOPY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BREAST MILK; CLINICAL OUTCOME; CONSUMER; DRUG EFFECT; ECZEMA; EPIGENETICS; FOOD ALLERGY; HIGH RISK INFANT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VIVO STUDY; INTESTINE FLORA; META ANALYSIS (TOPIC); PATIENT SAFETY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT ALLERGY; REVIEW; TREATMENT RESPONSE; UNCERTAINTY; VERTICAL TRANSMISSION; BREAST FEEDING; FEMALE; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MICROFLORA; PREGNANCY;

BREAST FEEDING; ECZEMA; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MICROBIOTA; PREBIOTICS; PREGNANCY; PROBIOTICS; SYNBIOTICS;

EID: 84997190809     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12838     Document Type: Review

References (122)

1. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2014; 45:43–53.
2. Wesemann DR, Nagler CR. The microbiome, timing, and barrier function in the context of allergic disease. Immunity 2016; 44:728–38.
3. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516–20.
4. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129–34.
5. Penders J, Thijs C, van den Brandt PA et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56:661–7.
6. Sjögren YM, Jenmalm MC, Böttcher MF, Björkstén B, Sverremark-Ekström E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009; 39:518–26.
7. Bisgaard H, Li N, Bonnelykke K et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011; 128:646–52 e1-5.
8. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129:434–40 40e1-2.
9. Ismail IH, Oppedisano F, Joseph SJ et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 2012; 23:674–81.
10. Penders J, Gerhold K, Stobberingh EE et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 2013; 132:601–7 e8.
11. Azad MB, Konya T, Guttman DS et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy 2015; 45:632–43.
12. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 2014; 44:842–50.
13. West CE, Ryden P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy 2015; 45:1419–29.
14. Arrieta MC, Stiemsma LT, Dimitriu PA et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015; 7:307ra152.
15. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 2013; 3:CD006474.
16. Cuello-Garcia CA, Brozek JL, Fiocchi A et al. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2015; 136:952–61.
17. West CE, Jenmalm MC, Kozyrskyj AL, Prescott SL. Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward. Exp Rev Clin Immunol 2016; 12:625–39.
18. FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties in food including powder milk with live lactic acid bacteria., 2001.
19. Boyle RJ, Ismail IH, Kivivuori S et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011; 66:509–16.
20. Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163:616–23.
21. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130:1355–60.
22. Ou CY, Kuo HC, Wang L et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2012; 42:1386–96.
23. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076–9.
24. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121:e850–6.
25. Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192–8.
26. Abrahamsson TR, Jakobsson T, Böttcher MF et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174–80.
27. Wickens K, Black PN, Stanley TV et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788–94.
28. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008; 38:1342–8.
29. Niers L, Martin R, Rijkers G et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64:1349–58.
30. Kim JY, Kwon JH, Ahn SH et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21:e386–93.
31. Allen SJ, Jordan S, Storey M et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child 2014; 99:1014–9.
32. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119:184–91.
33. Soh SE, Aw M, Gerez I et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants–effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39:571–8.
34. West CE, Hammarström ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20:430–7.
35. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1019–21.
36. Kuitunen M, Kukkonen K, Juntunen-Backman K et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123:335–41.
37. Abrahamsson TR, Jakobsson T, Björkstén B, Oldaeus G, Jenmalm MC. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24:556–61.
38. Wickens K, Stanley TV, Mitchell EA et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013; 43:1048–57.
39. Jensen MP, Meldrum S, Taylor AL, Dunstan JA, Prescott SL. Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol 2012; 130:1209–11 e5.
40. Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW, Shek LP. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol 2014; 163:25–8.
41. West CE, Hammarstrom ML, Hernell O. Probiotics in primary prevention of allergic disease–follow-up at 8-9 years of age. Allergy 2013; 68:1015–20.
42. Gorissen DM, Rutten NB, Oostermeijer CM et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study. Clin Exp Allergy 2014; 44:1431–3.
43. Simpson MR, Dotterud CK, Storro O, Johnsen R, Oien T. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol 2015; 15:13.
44. Zuccotti G, Meneghin F, Aceti A et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy 2015; 70:1356–71.
45. Zhang GQ, Hu HJ, Liu CY, Zhang Q, Shakya S, Li ZY. Probiotics for prevention of atopy and food hypersensitivity in early childhood: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2016; 95:e2562.
46. Muraro A, Halken S, Arshad SH et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014; 69:590–601.
47. Azad MB, Coneys JG, Kozyrskyj AL et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ 2013; 347:f6471.
48. Cuello-Garcia CA, Fiocchi A, Pawankar R et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): prebiotics. World Allergy Organ J 2016; 9:10.
49. Bode L. The functional biology of human milk oligosaccharides. Early Hum Dev 2015; 91:619–22.
50. Fiocchi A, Pawankar R, Cuello-Garcia C et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics. World Allergy Organ J 2015; 8:4.
51. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006; 91:814–9.
52. Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012; 26:49–59.
53. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008; 138:1091–5.
54. Ivakhnenko OS, Nyankovskyy SL. Effect of the specific infant formula mixture of oligosaccharides on local immunity and development of allergic and infectious disease in young children: randomized study. Pediatr Pol 2013; 88:398–404.
55. Gruber C, van Stuijvenberg M, Mosca F et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126:791–7.
56. Gruber C, van Stuivenberg M, Mosca F et al. Immunoactive prebiotics transiently prevent occurrence of early atopic dermatitis among low-atopy-risk infants. J Allergy Clin Immunol 2015; 136:1696–8 e1.
57. Roze JC, Barbarot S, Butel MJ et al. An alpha-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial. Br J Nutr 2012; 107:1616–22.
58. Chang YS, Trivedi MK, Jha A, Lin YF, Dimaano L, Garcia-Romero MT. Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr 2016; 170:236–42.
59. Thomas DW, Greer FR, American Academy of Pediatrics Committee on N, American Academy of Pediatrics Section on Gastroenterology H. Nutrition, Probiotics and prebiotics in pediatrics. Pediatrics 2010; 126:1217–31.
60. Braegger C, Chmielewska A, Decsi T et al. Nutrition ECo, Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52:238–50.
61. Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 2012; 46(Suppl):S1–2.
62. Panel NI-SE, Boyce JA, Assa'ad A et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:S1–58.
63. Jenmalm MC. Childhood immune maturation and allergy development: regulation by maternal immunity and microbial exposure. Am J Reprod Immunol 2011; 66(Suppl. 1):75–80.
64. Jenmalm MC, Duchén K. Timing of allergy-preventive and immunomodulatory dietary interventions - are prenatal, perinatal or postnatal strategies optimal? Clin Exp Allergy 2013; 43:273–8.
65. Abrahamsson TR, Wu RY, Jenmalm MC. Gut microbiota and allergy: the importance of the pregnancy period. Pediatr Res 2014; 77:214–9.
66. von Mutius E. The microbial environment and its influence on asthma prevention in early life. J Allergy Clin Immunol 2016; 137:680–9.
67. Gollwitzer ES, Marsland BJ. Impact of early-life exposures on immune maturation and susceptibility to disease. Trends Immunol 2015; 36:684–96.
68. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T et al. The maternal microbiota drives early postnatal innate immune development. Science 2016; 351:1296–302.
69. Funkhouser LJ, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 2013; 11:e1001631.
70. van Nimwegen FA, Penders J, Stobberingh EE et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 2011; 128:948–55 e1-3.
71. Jakobsson HE, Abrahamsson TR, Jenmalm MC et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 2014; 63:559–66.
72. Bäckhed F, Roswall J, Peng Y et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17:852.
73. Azad MB, Konya T, Persaud RR et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 2016; 123:983–93.
74. Dogra S, Sakwinska O, Soh SE et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 2015; 6:e02419–14.
75. Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Björkstén B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr 2009; 49:349–54.
76. Mastromarino P, Capobianco D, Miccheli A et al. Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery. Pharmacol Res 2015; 95–96:63–70.
77. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6:237ra65.
78. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016; 6:23129.
79. Stout MJ, Conlon B, Landeau M et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol 2013; 208:226 e1-7.
80. Satokari R, Gronroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 2009; 48:8–12.
81. Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 2012; 102:178–84.
82. Jimenez E, Fernandez L, Marin ML et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 2005; 51:270–4.
83. Jimenez E, Marin ML, Martin R et al. Is meconium from healthy newborns actually sterile? Res Microbiol 2008; 159:187–93.
84. Gosalbes MJ, Llop S, Valles Y, Moya A, Ballester F, Francino MP. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy 2013; 43:198–211.
85. Perez PF, Dore J, Leclerc M et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 2007; 119:e724–32.
86. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22:250–3.
87. West CE, Jenmalm MC. Transfer of probiotic bacteria from mother to child: a matter of strain specificity? J Pediatr Gastroenterol Nutr 2015; 61:157–8.
88. Dotterud CK, Avershina E, Sekelja M et al. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? J Pediatr Gastroenterol Nutr 2015; 61:200–7.
89. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119–21.
90. Böttcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Björkstén B. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2008; 19:497–504.
91. Kuitunen M, Kukkonen AK, Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol 2012; 159:162–70.
92. Savilahti EM, Kukkonen AK, Kuitunen M, Savilahti E. Soluble CD14, alpha-and beta-defensins in breast milk: association with the emergence of allergy in a high-risk population. Innate Immun 2015; 21:332–7.
93. Prescott SL, Wickens K, Westcott L et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy 2008; 38:1606–14.
94. Boyle RJ, Mah LJ, Chen A, Kivivuori S, Robins-Browne RM, Tang ML. Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses. Clin Exp Allergy 2008; 38:1882–90.
95. Kopp MV, Goldstein M, Dietschek A, Sofke J, Heinzmann A, Urbanek R. Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates. Clin Exp Allergy 2008; 38:602–10.
96. Forsberg A, Abrahamsson TR, Björkstén B, Jenmalm MC. Pre- and postnatal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy 2013; 43:434–42.
97. Forsberg A, Abrahamsson TR, Björkstén B, Jenmalm MC. Pre- and postnatal administration of Lactobacillus reuteri decreases TLR2 responses in infants. Clin Transl Allergy 2014; 4:21.
98. Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy 2006; 36:1227–35.
99. Taylor A, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy. Clin Exp Allergy 2006; 36:1218–26.
100. Taylor AL, Hale J, Hales BJ, Dunstan JA, Thomas WR, Prescott SL. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol 2007; 18:10–9.
101. West CE, Hernell O, Andersson Y, Sjöstedt M, Hammarström ML. Probiotic effects on T-cell maturation in infants during weaning. Clin Exp Allergy 2012; 42:540–9.
102. Marschan E, Kuitunen M, Kukkonen K et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38:611–8.
103. Abrahamsson TR, Sandberg Abelius M, Forsberg A, Björkstén B, Jenmalm MC. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy 2011; 41:1729–39.
104. Soh SE, Ong DQ, Gerez I et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010; 28:2577–9.
105. West CE, Gothefors L, Granstrom M, Kayhty H, Hammarstrom ML, Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2008; 19:53–60.
106. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy–a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006; 17:416–21.
107. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014; 69:3–16.
108. Marlow G, Han DY, Wickens K et al. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatr Allergy Immunol 2015; 26:262–71.
109. Morgan AR, Han DY, Wickens K et al. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy 2014; 44:1255–65.
110. Embleton ND, Zalewski S, Berrington JE. Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants. Curr Opin Infect Dis 2016; 29:256–61.
111. Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can 2009; 31:542–52.
112. Karlsson Videhult F, Ohlund I, Stenlund H, Hernell O, West CE. Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age. Eur J Nutr 2015; 54:355–63.
113. Kukkonen K, Savilahti E, Haahtela T et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122:8–12.
114. Laitinen K, Kalliomaki M, Poussa T, Lagstrom H, Isolauri E. Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. Br J Nutr 2005; 94:565–74.
115. Kuitunen M, Kukkonen K, Savilahti E. Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants. J Pediatr Gastroenterol Nutr 2009; 49:626–30.
116. Lahtinen SJ, Boyle RJ, Kivivuori S et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 2009; 123:499–501.
117. Gueimonde M, Sakata S, Kalliomaki M, Isolauri E, Benno Y, Salminen S. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr 2006; 42:166–70.
118. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Robins-Browne RM, Tang ML. Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol 2012; 23:255–8.
119. Rutten NB, Gorissen DM, Eck A et al. Long term development of gut microbiota composition in atopic children: impact of probiotics. PLoS ONE 2015; 10:e0137681.
120. Abrahamsson TR. Not all probiotic strains prevent necrotising enterocolitis in premature infants. Lancet 2016; 387:624–5.
121. West CE, Renz H, Jenmalm MC et al., in FMIG. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 2015; 135:3–13; quiz 14.
122. West CE. Probiotics for allergy prevention. Benef Microbes 2016; 7:171–9.